May 8, 2018 / 10:08 AM / 16 days ago

BRIEF-Lupin Submits New Drug Application For Etanercept Biosimilar In Japan

May 8 (Reuters) - Lupin Ltd:

* SAYS SUBMITS NEW DRUG APPLICATION FOR ETANERCEPT BIOSIMILAR IN JAPAN

* SAYS APPLICATION FOR A DRUG TO TREAT INDICATIONS FOR MODERATE TO SEVERE RHEUMATOID ARTHRITIS, JUVENILE IDIOPATHIC ARTHRITIS

* IS ALSO ON COURSE WITH PLANS FOR FILING IN U.S.; TARGETING A FILING IN FY 2019-20 Source text: bit.ly/2wm0YAa Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below